Renovaro Inc. (RENB)
NASDAQ: RENB · Real-Time Price · USD
0.3634
-0.0098 (-2.63%)
Apr 28, 2025, 4:00 PM EDT - Market closed
Renovaro Employees
Renovaro had 25 employees as of June 30, 2024. The number of employees increased by 13 or 108.33% compared to the previous year.
Employees
25
Change (1Y)
13
Growth (1Y)
108.33%
Revenue / Employee
n/a
Profits / Employee
-$4,736,418
Market Cap
58.18M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
| AbbVie | 55,000 |
RENB News
- 6 days ago - Renovaro Secures High-Powered Computing from Nebul Through a Partnership to Accelerate Next-Generation Biomarker Discovery and Diagnostic Programs - GlobeNewsWire
- 19 days ago - Renovaro and BioSymetrics Close Merger to Accelerate AI-Driven Biomarker Discovery and Precision Medicine - GlobeNewsWire
- 24 days ago - Renovaro Provides Update to Definitive Agreement with Predictive Oncology - GlobeNewsWire
- 2 months ago - Renovaro Completes First Milestone Payment to Finalize Definitive Agreement with Predictive Oncology - GlobeNewsWire
- 2 months ago - Renovaro and BioSymetrics Announce Definitive Merger Agreement to Advance AI-Driven Biomarker Discovery and Precision Medicine - GlobeNewsWire
- 2 months ago - Renovaro Announces $15 million in Equity Committed - GlobeNewsWire
- 3 months ago - PREDICTIVE ONCOLOGY INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Predictive Oncology Inc. - POAI - Business Wire
- 3 months ago - Renovaro Appoints Nathen Fuentes as Chief Financial Officer - GlobeNewsWire